期刊
FRONTIERS IN MARINE SCIENCE
卷 7, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fmars.2020.614766
关键词
cancer hallmarks; natural products; marine biodiversity; cancer therapy; marine medicine
资金
- Nicholas Institute
- Duke University Nicholas School of the Environment
Marine ecosystems hold over 80% of the world's biodiversity, offering a largely untapped resource for novel compounds to combat human diseases such as cancer. While most current anti-cancer drugs are derived from terrestrial ecosystems, there are promising marine-derived compounds that have been approved or are in clinical trials for their anti-cancer potential.
Marine ecosystems contain over 80% of the world's biodiversity, and many of these organisms have evolved unique adaptations enabling survival in diverse and challenging environments. The biodiversity within the world's oceans is a virtually untapped resource for the isolation and development of novel compounds, treatments, and solutions to combat human disease. In particular, while over half of our anti-cancer drugs are derived from natural sources, almost all of these are from terrestrial ecosystems. Yet, even from the limited analyses to date, a number of marine-derived anti-cancer compounds have been approved for clinical use, and several others are currently in clinical trials. Here, we review the current suite of marine-derived anti-cancer drugs, with a focus on how these compounds act upon the hallmarks of cancer. We highlight potential marine environments and species that could yield compounds with unique mechanisms. Continued exploration of marine environments, along with the characterization and screening of their inhabitants for unique bioactive chemicals, could prove fruitful in the hunt for novel anti-cancer therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据